ID-Checker Technology for the Highly Selective Macroscale Delivery of Anticancer Agents to the Cancer Cells

Cancer cells deploy several glucose transport protein (GLUT) channels on the cell membranes to increase glucose uptake. Cancer cells die within 24 h in the absence of glucose. Thus, preventing the deployment of GLUT channels can deprive them of glucose, resulting in apoptosis within 24 h. Herein, we...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2022-10, Vol.65 (19), p.12883-12894
Main Authors: Song, Keum-soo, Nimse, Satish Balasaheb, Kim, Junghoon, Warkad, Shrikant Dashrath, Kim, Taisun
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a426t-1b4afff52082ce190f36a6209d5898cb73dcca5b9d61d8e457b5aa7d4b12ea923
cites cdi_FETCH-LOGICAL-a426t-1b4afff52082ce190f36a6209d5898cb73dcca5b9d61d8e457b5aa7d4b12ea923
container_end_page 12894
container_issue 19
container_start_page 12883
container_title Journal of medicinal chemistry
container_volume 65
creator Song, Keum-soo
Nimse, Satish Balasaheb
Kim, Junghoon
Warkad, Shrikant Dashrath
Kim, Taisun
description Cancer cells deploy several glucose transport protein (GLUT) channels on the cell membranes to increase glucose uptake. Cancer cells die within 24 h in the absence of glucose. Thus, preventing the deployment of GLUT channels can deprive them of glucose, resulting in apoptosis within 24 h. Herein, we developed the ID-Checker with a glucose tag that ensures its highly specific macroscale delivery of anticancer agents to the cancer cells through the GLUT channels. ID-Checker presented here showed IC50 values of 0.17–0.27 and 3.34 μM in cancer and normal cell lines, respectively. ID-Checker showed a selectivity index of 12.5–20.2, which is about 10–20 times higher than that of known anticancer agents such as colchicine. ID-Checker inhibits the microtubule formation, which results in the prevention of the deployment of GLUT channels in 6 h and kills the cancer cells within 24 h without any damage to normal cells.
doi_str_mv 10.1021/acs.jmedchem.2c00646
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9575670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2721636034</sourcerecordid><originalsourceid>FETCH-LOGICAL-a426t-1b4afff52082ce190f36a6209d5898cb73dcca5b9d61d8e457b5aa7d4b12ea923</originalsourceid><addsrcrecordid>eNp9kT9v2zAQxYmgQeMm_QYZOGaRe_wjSloCGErbBHDRIclMUNTJkk2LLikH8LcvHbsFunQicHfvx7v3CLllMGfA2Rdj43y9xdb2uJ1zC6CkuiAzlnPIZAnyA5kBcJ5xxcUV-RTjGgAE4-IjuRKKVbLgckY2Tw9Z3aPdYKAvaPvRO7860M4HOvVIH4dV7w70GR3aaXhD-sPY4KM1DukDulQJB-o7uhinwZrRJspiheMU6eTfAfWpWKNz8YZcdsZF_Hx-r8nrt68v9WO2_Pn9qV4sMyO5mjLWSNN1Xbqj5BZZBZ1QRnGo2rysStsUorXW5E3VKtaWKPOiyY0pWtkwjqbi4prcn7i7fXM0KO0TjNO7MGxNOGhvBv1vZxx6vfJvusqLXBWQAHdnQPC_9hgnvR2iTSeYEf0-al5wpoQCIdOoPI0ebYkBu7_fMNDHnHTKSf_JSZ9zSjI4yd67fh_GZMj_Jb8BQ1SaZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2721636034</pqid></control><display><type>article</type><title>ID-Checker Technology for the Highly Selective Macroscale Delivery of Anticancer Agents to the Cancer Cells</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Song, Keum-soo ; Nimse, Satish Balasaheb ; Kim, Junghoon ; Warkad, Shrikant Dashrath ; Kim, Taisun</creator><creatorcontrib>Song, Keum-soo ; Nimse, Satish Balasaheb ; Kim, Junghoon ; Warkad, Shrikant Dashrath ; Kim, Taisun</creatorcontrib><description>Cancer cells deploy several glucose transport protein (GLUT) channels on the cell membranes to increase glucose uptake. Cancer cells die within 24 h in the absence of glucose. Thus, preventing the deployment of GLUT channels can deprive them of glucose, resulting in apoptosis within 24 h. Herein, we developed the ID-Checker with a glucose tag that ensures its highly specific macroscale delivery of anticancer agents to the cancer cells through the GLUT channels. ID-Checker presented here showed IC50 values of 0.17–0.27 and 3.34 μM in cancer and normal cell lines, respectively. ID-Checker showed a selectivity index of 12.5–20.2, which is about 10–20 times higher than that of known anticancer agents such as colchicine. ID-Checker inhibits the microtubule formation, which results in the prevention of the deployment of GLUT channels in 6 h and kills the cancer cells within 24 h without any damage to normal cells.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.2c00646</identifier><identifier>PMID: 36194724</identifier><language>eng</language><publisher>American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2022-10, Vol.65 (19), p.12883-12894</ispartof><rights>2022 The Authors. Published by American Chemical Society</rights><rights>2022 The Authors. Published by American Chemical Society 2022 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a426t-1b4afff52082ce190f36a6209d5898cb73dcca5b9d61d8e457b5aa7d4b12ea923</citedby><cites>FETCH-LOGICAL-a426t-1b4afff52082ce190f36a6209d5898cb73dcca5b9d61d8e457b5aa7d4b12ea923</cites><orcidid>0000-0002-5137-0584 ; 0000-0002-7834-575X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Song, Keum-soo</creatorcontrib><creatorcontrib>Nimse, Satish Balasaheb</creatorcontrib><creatorcontrib>Kim, Junghoon</creatorcontrib><creatorcontrib>Warkad, Shrikant Dashrath</creatorcontrib><creatorcontrib>Kim, Taisun</creatorcontrib><title>ID-Checker Technology for the Highly Selective Macroscale Delivery of Anticancer Agents to the Cancer Cells</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Cancer cells deploy several glucose transport protein (GLUT) channels on the cell membranes to increase glucose uptake. Cancer cells die within 24 h in the absence of glucose. Thus, preventing the deployment of GLUT channels can deprive them of glucose, resulting in apoptosis within 24 h. Herein, we developed the ID-Checker with a glucose tag that ensures its highly specific macroscale delivery of anticancer agents to the cancer cells through the GLUT channels. ID-Checker presented here showed IC50 values of 0.17–0.27 and 3.34 μM in cancer and normal cell lines, respectively. ID-Checker showed a selectivity index of 12.5–20.2, which is about 10–20 times higher than that of known anticancer agents such as colchicine. ID-Checker inhibits the microtubule formation, which results in the prevention of the deployment of GLUT channels in 6 h and kills the cancer cells within 24 h without any damage to normal cells.</description><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kT9v2zAQxYmgQeMm_QYZOGaRe_wjSloCGErbBHDRIclMUNTJkk2LLikH8LcvHbsFunQicHfvx7v3CLllMGfA2Rdj43y9xdb2uJ1zC6CkuiAzlnPIZAnyA5kBcJ5xxcUV-RTjGgAE4-IjuRKKVbLgckY2Tw9Z3aPdYKAvaPvRO7860M4HOvVIH4dV7w70GR3aaXhD-sPY4KM1DukDulQJB-o7uhinwZrRJspiheMU6eTfAfWpWKNz8YZcdsZF_Hx-r8nrt68v9WO2_Pn9qV4sMyO5mjLWSNN1Xbqj5BZZBZ1QRnGo2rysStsUorXW5E3VKtaWKPOiyY0pWtkwjqbi4prcn7i7fXM0KO0TjNO7MGxNOGhvBv1vZxx6vfJvusqLXBWQAHdnQPC_9hgnvR2iTSeYEf0-al5wpoQCIdOoPI0ebYkBu7_fMNDHnHTKSf_JSZ9zSjI4yd67fh_GZMj_Jb8BQ1SaZA</recordid><startdate>20221013</startdate><enddate>20221013</enddate><creator>Song, Keum-soo</creator><creator>Nimse, Satish Balasaheb</creator><creator>Kim, Junghoon</creator><creator>Warkad, Shrikant Dashrath</creator><creator>Kim, Taisun</creator><general>American Chemical Society</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5137-0584</orcidid><orcidid>https://orcid.org/0000-0002-7834-575X</orcidid></search><sort><creationdate>20221013</creationdate><title>ID-Checker Technology for the Highly Selective Macroscale Delivery of Anticancer Agents to the Cancer Cells</title><author>Song, Keum-soo ; Nimse, Satish Balasaheb ; Kim, Junghoon ; Warkad, Shrikant Dashrath ; Kim, Taisun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a426t-1b4afff52082ce190f36a6209d5898cb73dcca5b9d61d8e457b5aa7d4b12ea923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Keum-soo</creatorcontrib><creatorcontrib>Nimse, Satish Balasaheb</creatorcontrib><creatorcontrib>Kim, Junghoon</creatorcontrib><creatorcontrib>Warkad, Shrikant Dashrath</creatorcontrib><creatorcontrib>Kim, Taisun</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Keum-soo</au><au>Nimse, Satish Balasaheb</au><au>Kim, Junghoon</au><au>Warkad, Shrikant Dashrath</au><au>Kim, Taisun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ID-Checker Technology for the Highly Selective Macroscale Delivery of Anticancer Agents to the Cancer Cells</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2022-10-13</date><risdate>2022</risdate><volume>65</volume><issue>19</issue><spage>12883</spage><epage>12894</epage><pages>12883-12894</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Cancer cells deploy several glucose transport protein (GLUT) channels on the cell membranes to increase glucose uptake. Cancer cells die within 24 h in the absence of glucose. Thus, preventing the deployment of GLUT channels can deprive them of glucose, resulting in apoptosis within 24 h. Herein, we developed the ID-Checker with a glucose tag that ensures its highly specific macroscale delivery of anticancer agents to the cancer cells through the GLUT channels. ID-Checker presented here showed IC50 values of 0.17–0.27 and 3.34 μM in cancer and normal cell lines, respectively. ID-Checker showed a selectivity index of 12.5–20.2, which is about 10–20 times higher than that of known anticancer agents such as colchicine. ID-Checker inhibits the microtubule formation, which results in the prevention of the deployment of GLUT channels in 6 h and kills the cancer cells within 24 h without any damage to normal cells.</abstract><pub>American Chemical Society</pub><pmid>36194724</pmid><doi>10.1021/acs.jmedchem.2c00646</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-5137-0584</orcidid><orcidid>https://orcid.org/0000-0002-7834-575X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2022-10, Vol.65 (19), p.12883-12894
issn 0022-2623
1520-4804
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9575670
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
title ID-Checker Technology for the Highly Selective Macroscale Delivery of Anticancer Agents to the Cancer Cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A23%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ID-Checker%20Technology%20for%20the%20Highly%20Selective%20Macroscale%20Delivery%20of%20Anticancer%20Agents%20to%20the%20Cancer%20Cells&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Song,%20Keum-soo&rft.date=2022-10-13&rft.volume=65&rft.issue=19&rft.spage=12883&rft.epage=12894&rft.pages=12883-12894&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.2c00646&rft_dat=%3Cproquest_pubme%3E2721636034%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a426t-1b4afff52082ce190f36a6209d5898cb73dcca5b9d61d8e457b5aa7d4b12ea923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2721636034&rft_id=info:pmid/36194724&rfr_iscdi=true